Novartis AG (NVS)
102.10
+1.90
(+1.89%)
USD |
NYSE |
May 10, 16:00
102.59
+0.48
(+0.48%)
After-Hours: 19:46
Novartis Total Return Level: 209.60 for May 9, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 09, 2024 | 209.60 |
May 08, 2024 | 208.32 |
May 07, 2024 | 207.21 |
May 06, 2024 | 204.41 |
May 03, 2024 | 203.45 |
May 02, 2024 | 203.60 |
May 01, 2024 | 203.93 |
April 30, 2024 | 203.16 |
April 29, 2024 | 203.07 |
April 26, 2024 | 203.80 |
April 25, 2024 | 207.19 |
April 24, 2024 | 205.71 |
April 23, 2024 | 203.47 |
April 22, 2024 | 198.95 |
April 19, 2024 | 197.36 |
April 18, 2024 | 193.62 |
April 17, 2024 | 194.69 |
April 16, 2024 | 194.94 |
April 15, 2024 | 197.47 |
April 12, 2024 | 195.61 |
April 11, 2024 | 197.32 |
April 10, 2024 | 197.40 |
April 09, 2024 | 200.40 |
April 08, 2024 | 199.70 |
April 05, 2024 | 200.35 |
Date | Value |
---|---|
April 04, 2024 | 202.65 |
April 03, 2024 | 197.38 |
April 02, 2024 | 197.47 |
April 01, 2024 | 200.52 |
March 28, 2024 | 202.32 |
March 27, 2024 | 200.54 |
March 26, 2024 | 199.27 |
March 25, 2024 | 200.23 |
March 22, 2024 | 201.27 |
March 21, 2024 | 200.96 |
March 20, 2024 | 200.90 |
March 19, 2024 | 201.46 |
March 18, 2024 | 200.63 |
March 15, 2024 | 203.45 |
March 14, 2024 | 205.25 |
March 13, 2024 | 207.07 |
March 12, 2024 | 208.68 |
March 11, 2024 | 212.02 |
March 08, 2024 | 210.64 |
March 07, 2024 | 209.01 |
March 06, 2024 | 206.86 |
March 05, 2024 | 205.77 |
March 04, 2024 | 205.51 |
March 01, 2024 | 205.69 |
February 29, 2024 | 203.50 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
126.19
Minimum
Mar 23 2020
218.61
Maximum
Jan 22 2024
169.13
Average
162.75
Median
Jan 31 2020
Total Return Level Benchmarks
Roche Holding AG | 60.26 |
Sandoz Group AG | 35.48 |
Amgen Inc | 434.89 |
Incyte Corp | 53.53 |
MorphoSys AG | 17.88 |